Pages that link to "Q39436413"
Jump to navigation
Jump to search
The following pages link to Temozolomide: mechanisms of action, repair and resistance (Q39436413):
Displaying 50 items.
- Glioblastoma cancer stem cells: Biomarker and therapeutic advances (Q26859782) (← links)
- Molecular characteristics of pediatric high-grade gliomas (Q26860786) (← links)
- Targeting autophagy to sensitive glioma to temozolomide treatment (Q28066270) (← links)
- Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic (Q28071541) (← links)
- The role of p53 in cancer drug resistance and targeted chemotherapy (Q28072553) (← links)
- What next for newly diagnosed glioblastoma? (Q28086839) (← links)
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression (Q28550138) (← links)
- Fluorogenic Real-Time Reporters of DNA Repair by MGMT, a Clinical Predictor of Antitumor Drug Response (Q28551141) (← links)
- IGF-IR: a new prognostic biomarker for human glioblastoma (Q30375102) (← links)
- The NCI-60 Methylome and Its Integration into CellMiner (Q30490461) (← links)
- Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance. (Q33613608) (← links)
- Modulation of trinucleotide repeat instability by DNA polymerase β polymorphic variant R137Q. (Q33643405) (← links)
- Rosa26-GFP direct repeat (RaDR-GFP) mice reveal tissue- and age-dependence of homologous recombination in mammals in vivo. (Q33716551) (← links)
- The rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort (Q33757960) (← links)
- Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates (Q33808096) (← links)
- APNG as a prognostic marker in patients with glioblastoma. (Q33852894) (← links)
- HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines (Q33925330) (← links)
- The medicinal chemistry of imidazotetrazine prodrugs (Q33963114) (← links)
- Synthesis and quantitative structure-activity relationship of imidazotetrazine prodrugs with activity independent of O6-methylguanine-DNA-methyltransferase, DNA mismatch repair, and p53. (Q34447471) (← links)
- Overcoming multiple drug resistance mechanisms in medulloblastoma. (Q34500602) (← links)
- Nanotube x-ray for cancer therapy: a compact microbeam radiation therapy system for brain tumor treatment (Q34662481) (← links)
- Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation (Q35234429) (← links)
- Hispidulin enhances the anti-tumor effects of temozolomide in glioblastoma by activating AMPK. (Q35332213) (← links)
- A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion (Q35731493) (← links)
- Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens (Q35755496) (← links)
- Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo (Q35965268) (← links)
- Targeting the parasite's DNA with methyltriazenyl purine analogs is a safe, selective, and efficacious antitrypanosomal strategy (Q36158447) (← links)
- Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas (Q36651893) (← links)
- Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer (Q36657222) (← links)
- Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation (Q36738925) (← links)
- A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT. (Q36951049) (← links)
- Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy (Q36954125) (← links)
- Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression (Q37144157) (← links)
- Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma (Q37153084) (← links)
- Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression (Q37232935) (← links)
- Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions (Q37268884) (← links)
- Glioblastoma multiforme therapy and mechanisms of resistance. (Q37415954) (← links)
- CBX Chromodomain Inhibition Enhances Chemotherapy Response in Glioblastoma Multiforme. (Q37517517) (← links)
- ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis (Q37536711) (← links)
- Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines (Q37536715) (← links)
- Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models (Q37615383) (← links)
- Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide (Q37641600) (← links)
- Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition (Q37684589) (← links)
- MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis (Q37686230) (← links)
- Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro (Q37701123) (← links)
- A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma (Q37710210) (← links)
- PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas (Q37716625) (← links)
- Progression of O⁶-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research (Q38225830) (← links)
- Glioblastoma multiforme: State of the art and future therapeutics (Q38225874) (← links)
- Current evidence of temozolomide and bevacizumab in treatment of gliomas. (Q38230650) (← links)